| Literature DB >> 31496763 |
Qi Zhang1, Min Zhao1, Mei Xu1, Fengjuan Gu1, Quan Liu1, Yuan Chen2, Haiqi Zhang1, Aize Kijlstra3.
Abstract
PURPOSE: This study aimed to evaluate the outcomes of therapeutic keratoplasty for severe infectious keratitis in Chongqing (Southwest China). PATIENTS AND METHODS: The records of 561 eyes that underwent therapeutic keratoplasty for refractory microbial keratitis from 2001 to 2016 were analyzed in this retrospective study. Data included demographic information, microbiological investigations, associated factors, graft size, preoperative status, postoperative complications, and final anatomical outcomes.Entities:
Keywords: corneal ulcer; infectious keratitis; therapeutic keratoplasty
Year: 2019 PMID: 31496763 PMCID: PMC6697658 DOI: 10.2147/IDR.S204025
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Etiological diagnosis and associated factors for infectious keratitis
| Associated factors | Bacteria | Fungus | Etiology (No.) | Unproven | Total (%) | |
|---|---|---|---|---|---|---|
| Acanthamoeba | Mixed | |||||
| Plant-induced trauma | 16 | 128 | 0 | 6 | 15 | 165 (29.4) |
| Other trauma | 23 | 36 | 1 | 4 | 38 | 102 (18.2) |
| Diabetes | 10 | 33 | 0 | 1 | 26 | 70 (12.5) |
| Ocular surface disorder | 7 | 28 | 0 | 0 | 12 | 47 (8.4) |
| Respiratory infection | 3 | 17 | 0 | 0 | 4 | 24 (4.3) |
| Dacryocystitis | 9 | 0 | 0 | 0 | 12 | 21 (3.7) |
| Contact lens | 8 | 0 | 2 | 0 | 9 | 19 (3.4) |
| Others | 2 | 6 | 0 | 0 | 9 | 17 (3.0) |
| None | 2 | 69 | 0 | 4 | 21 | 96 (17.1) |
| Total (%) | 80 (14.3%) | 317 (56.5%) | 3 (0.5%) | 15 (2.7%) | 146 (26.0%) | 561 (100%) |
Abbreviation: Mixed, mixed bacterial and fungal infection.
Anatomical outcomes after therapeutic keratoplasty
| Etiology (No.) | Anatomical Success (%) |
|---|---|
| Bacteria (80) | 76 (95.0%) |
| Fungus (317) | 267 (84.2%) |
| Acanthamoeba (3) | 2 (66.7%) |
| Mixed (15) | 11 (73.3%) |
| Unproven (146) | 136 (93.2%) |
| Total (561) | 492 (87.7%) |
Notes: P-value for anatomical success for bacterial and fungal keratitis is 0.012; P-value for anatomical success for bacterial and mixed keratitis is 0.020; P-value for anatomical success for fungal and mixed keratitis is 0.28
Abbreviation: Mixed, mixed bacterial and fungal infection.
Logistic regression of characteristics related to anatomical failure after therapeutic keratoplasty
| Characteristics | Anatomical Failure | Anatomical Success | Univariable analysis | Multivariable analysis * | ||
|---|---|---|---|---|---|---|
| N=69 | N=492 | OR (95% CI) | OR (95% CI) | |||
| Age | 54.1±16.3 | 52.9±17.8 | 0.509 | 0.176 (0.727–1.901) | 0.570 | 1.361 (0.470–3.944) |
| Male gender | 41 (59.4%) | 314 (63.8%) | 0.478 | 0.830 (0.496–1.389) | 0.663 | 0.782 (0.258–2.367) |
| Trauma | 39 (56.5%) | 228 (46.3%) | 0.115 | 1.505 (0.706–2.501) | 0.716 | 1.366 (0.254–7.343) |
| Diabetes | 14 (20.3%) | 56 (11.4%) | 0.039 | 1.982 (1.035–3.794) | 0.028 | 2.796 (1.115–7.009) |
| Ocular surface disorder | 9 (13.0%) | 38 (7.7%) | 0.140 | 1.792 (0.826–3.889) | 0.328 | 2.200 (0.454–10.662) |
| Respiratory infection | 5 (7.2%) | 19 (3.9%) | 0.201 | 1.945 (0.702–5.389) | 0.695 | 1.790 (0.097–32.946) |
| Dacryocystitis | 2 (2.9%) | 19 (3.9%) | 0.694 | 0.743 (0.169–3.262) | 0.929 | 0.867 (0.037–20.103) |
| Contact lens | 2 (2.9%) | 17 (3.5%) | 0.811 | 0.834 (0.188–3.691) | 0.938 | 0.901 (0.065–12.544) |
| Hypopyon | 54 (78.3%) | 341 (69.3%) | 0.130 | 1.594 (0.872–2.914) | 0.208 | 1.828 (0.715–4.671) |
| Corneal perforation | 15 (21.7%) | 71 (14.4%) | 0.118 | 1.647 (0.882–3.077) | 0.064 | 1.839 (0.965–3.502) |
| Preoperative time (≥30 days) | 34 (49.3%) | 165 (33.5%) | 0.011 | 1.925 (1.159–3.199) | 0.022 | 2.472 (1.143–5.347) |
| Size of graft (≥8.75 mm) | 53 (76.8%) | 336 (68.3%) | 0.153 | 1.538 (0.852–2.776) | 0.122 | 2.025 (0.828–4.949) |
Note: *All variables in the univariable analysis were included in the multivariable analysis.
Abbreviations: OR, odds ratio; 95% CI, 95% confidence interval.
Postoperative complications and associated characteristics
| Characteristic | Complications | Present | Absent | OR (95% CI) * | |
|---|---|---|---|---|---|
| No.of patients (%) | No.of patients (%) | ||||
| Hypopyon | Reinfection | 65/395 (16.5) | 16/166 (9.6) | 1.847 (1.034–3.298) | 0.036 |
| Rejection | 124/395 (31.4) | 43/166 (25.9) | 1.309 (0.871–1.966) | 0.194 | |
| Cataract | 303/395 (76.7) | 109/166 (65.7) | 1.722 (1.159–2.560) | 0.007 | |
| Glaucoma | 117/395 (29.6) | 32/166 (19.3) | 1.762 (1.133–2.742) | 0.011 | |
| Hyphema | 91/395 (23.0) | 30/166 (18.1) | 1.357 (0.857–2.148) | 0.192 | |
| Corneal perforation | Reinfection | 19/86 (22.1) | 62/475 (13.1) | 1.889 (1.063–3.357) | 0.028 |
| Rejection | 31/86 (36.0) | 136/475 (28.6) | 1.405 (0.867–2.278) | 0.166 | |
| Cataract | 75/86 (87.2) | 337/475 (70.9) | 2.792 (1.439–5.418) | 0.002 | |
| Glaucoma | 33/86 (38.4) | 116/475 (24.4) | 1.927 (1.190–3.122) | 0.007 | |
| Hyphema | 23/86 (26.7) | 98/475 (20.6) | 1.404 (0.830–2.378) | 0.205 | |
| Preoperative time | Reinfection | 43/199 (21.6) | 38/362 (10.5) | 2.350 (1.460–3.784) | 0.0003 |
| (≥30 days) | Rejection | 68/199 (34.2) | 99/362 (25.3) | 1.379 (0.950–2.003) | 0.091 |
| Cataract | 160/199 (80.4) | 252/362 (69.6) | 1.791 (1.182–2.713) | 0.006 | |
| Glaucoma | 65/199 (32.7) | 84/362 (23.2) | 1.605 (1.094–2.357) | 0.015 | |
| Hyphema | 55/199 (27.6) | 66/362 (18.2) | 1.713 (1.138–2.580) | 0.010 | |
| Size of graft | Reinfection | 63/389 (16.2) | 18/172 (10.5) | 1.653 (0.947–2.888) | 0.075 |
| (≥8.75 mm) | Rejection | 128/389 (32.9) | 39/172 (22.7) | 1.672 (1.104–2.532) | 0.015 |
| Cataract | 297/389 (76.3) | 115/172 (66.9) | 1.600 (1.079–2.374) | 0.019 | |
| Glaucoma | 114/389 (29.3) | 35/172 (20.3) | 1.623 (1.055–2.495) | 0.027 | |
| Hyphema | 93/389 (23.9) | 28/172 (16.3) | 1.616 (1.013–2.578) | 0.043 |
Note: *Univariable logistic regression.
Abbreviations: OR, odds ratio; 95% CI, 95% confidence interval.